Volume 108, Issue 11 , Pages 894-898, November 2009
The First Case of Severe Novel H1N1 Influenza Successfully Rescued by Extracorporeal Membrane Oxygenation in Taiwan
Article Outline
During the novel influenza A (H1N1) pandemic, some patients developed acute respiratory distress syndrome or severe cardiopulmonary failure despite the use of conventional management. Extracorporeal membrane oxygenation (ECMO) support may successfully rescue these severely ill patients. Here, we report the first case of severe novel H1N1 infection with multiorgan failure that was successfully treated with antiviral therapy and ECMO in Taiwan. A 32-year-old man had acute onset of fever, dry cough, rhinorrhea, and sore throat 2 days after returning from Dongguan, China. He attended Hospital A and chest radiography revealed bilateral lung consolidation. Rapid influenza antigen testing was negative. He was intubated 2 days later due to hypoxic respiratory failure and persistent shock refractory to conventional management. Because of compromised cardiopulmonary function, venoarterial ECMO support was started 4 days after the onset of symptoms and he was transferred to Hospital B on July 25, 2009. As history taking found clustering of influenza-like illness, oseltamivir was given immediately under the impression of severe influenza illness. Real-time reverse transcriptase-polymerase chain reaction of respiratory sample for novel H1N1 virus revealed positive results. In addition, blood cultures collected at Hospital A yielded Streptococcus pneumoniae, and β-hemolytic Streptococcus other than group A, B or D. Hospital course was uneventful and he was discharged 26 days after transfer to Hospital B. This experience showed that ECMO can be life-saving for severe novel H1N1 infection. [J Formos Med Assoc 2009;108(11):894–898]
Key Words: ECMO , novel H1N1 virus , oseltamivir , rapid influenza antigen testing
No full text is available. To read the body of this article, please view the PDF online.
References
- Emergence of a novel swine-origin influenza A (H1N1) virus in humans . N Engl J Med . 2009;361:1–10
- . DG Statement Following the Meeting of the Emergency Committee . Available at: http://www.who.int/csr/disease/swineflu/4th_meeting_ihr/en/index.html 2009; [Date accessed: September 9, 2009]
- . 2009 H1N1 Flu: International Situation Update . Available at: http://www.cdc.gov/h1n1flu/updates/international/092509.htm [Date accessed: September 28, 2009]
- Centers for Disease Control, Taiwan, R.O.C. Influenza Prevention . Available at: http://www.h1n1.gov.tw/lp.asp?ctNode=1476&CtUnit=779&BaseDSD=7&mp=150 [Date assessed: September 29, 2009]
- Extracorporeal membrane oxygenation: current clinical practice, coding, and reimbursement . Chest . 2008;134:179–184
- Extracorporeal membrane oxygenation for adult respiratory failure . Chest . 1997;112:759–764
- Extracorporeal life support for massive pulmonary embolism . J Trauma . 2007;62:570–576
- . Prolonged extracorporeal membrane oxygenation support for acute respiratory distress syndrome . J Formos Med Assoc . 2006;105:422–426
- . Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus – United States, 2009 . MMWR Morb Mortal Wkly Rep . 2009;58:826–829
- Low sensitivity of rapid diagnostic test for influenza . Clin Infect Dis . 2009;48:e89–e92
- . Rapid antigen tests for diagnosis of pandemic (swine) influenza A/H1N1 . Clin Infect Dis . 2009;49:1090–1093
- Seasonal influenza in adults and children—diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America . Clin Infect Dis . 2009;48:1003–1032
- Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza . JAMA . 2000;282:1016–1024
- Update on avian influenza A (H5N1) virus infection in humans . N Engl J Med . 2008;358:261–273
- . Intensive-care patients with severe novel influenza A (H1N1) virus infection – Michigan, June 2009 . MMWR Morb Mortal Wkly Rep . 2009;58:749–752
PII: S0929-6646(09)60422-8
doi:10.1016/S0929-6646(09)60422-8
© 2009 Formosan Medical Association & Elsevier. Published by Elsevier Inc. All rights reserved.
Volume 108, Issue 11 , Pages 894-898, November 2009
